HomeCompareSMEBF vs PFE

SMEBF vs PFE: Dividend Comparison 2026

SMEBF yields 5.63% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMEBF wins by $464.6K in total portfolio value
10 years
SMEBF
SMEBF
● Live price
5.63%
Share price
$0.56
Annual div
$0.03
5Y div CAGR
44.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$514.2K
Annual income
$276,115.16
Full SMEBF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SMEBF vs PFE

📍 SMEBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMEBFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMEBF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMEBF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMEBF
Annual income on $10K today (after 15% tax)
$478.61/yr
After 10yr DRIP, annual income (after tax)
$234,697.89/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, SMEBF beats the other by $212,377.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMEBF + PFE for your $10,000?

SMEBF: 50%PFE: 50%
100% PFE50/50100% SMEBF
Portfolio after 10yr
$281.9K
Annual income
$151,186.94/yr
Blended yield
53.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SMEBF
No analyst data
Altman Z
2.6
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMEBF buys
0
PFE buys
0
No recent congressional trades found for SMEBF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMEBFPFE
Forward yield5.63%6.13%
Annual dividend / share$0.03$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR44.8%13.2%
Portfolio after 10y$514.2K$49.6K
Annual income after 10y$276,115.16$26,258.71
Total dividends collected$466.3K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMEBF vs PFE ($10,000, DRIP)

YearSMEBF PortfolioSMEBF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,515$815.33$9,153$693.39+$2.4KSMEBF
2$13,592$1,270.55$8,593$849.25+$5.0KSMEBF
3$16,573$2,029.47$8,336$1,066.78+$8.2KSMEBF
4$21,082$3,348.76$8,437$1,384.80+$12.6KSMEBF
5$28,322$5,764.71$9,013$1,875.40+$19.3KSMEBF
6$40,785$10,480.51$10,306$2,680.72+$30.5KSMEBF
7$64,064$20,424.13$12,820$4,101.38+$51.2KSMEBF
8$111,964$43,415.18$17,673$6,826.70+$94.3KSMEBF
9$222,482$102,680.67$27,543$12,591.86+$194.9KSMEBF
10$514,171$276,115.16$49,560$26,258.71+$464.6KSMEBF

SMEBF vs PFE: Complete Analysis 2026

SMEBFStock

Sime Darby Berhad, an investment holding company, operates in the industrial, motors, logistics, healthcare, and other businesses in Malaysia and internationally. The company manufactures, assembles, and sells generators, and agricultural and industrial machineries; markets, installs, rents, and services security products; markets and installs electronic and electro-mechanical equipment, instruments, and systems integration; sells, rents, and assembles Caterpillar equipment and spare parts; reconditions used equipment and machineries; supplies global positioning systems/digital work site positioning, and machine control products for heavy and highway construction applications; sells lift trucks and spare parts, and services other material handling equipment; imports and sells technical, nautical, and scientific instruments, as well as mechanical, electrical, and electronic equipment; and sells, hires, and services survey and marine equipment. It also provides heat exchangers, radiators, process equipment modules, filters, and separators; training and security services; and consultancy and other services for installation, operation, repair, and maintenance of industrial machines, equipment, and vehicles. In addition, the company manufactures, sells, and distributes passenger and light commercial vehicles, and spare parts; imports and distributes motor vehicles; offers vehicle rental services; and engages in general investment activities. Further, it provides port and warehousing services; tugboat pilot, container, property management, and childcare services; and owns and manages logistics parks. Additionally, the company operates hospitals; provides insurance and reinsurance brokerage, and advisory services; and sells Trimble technical solutions, as well as provides engineering, procurement, construction, installation, hook-up, and commissioning services related to oil and gas industry. Sime Darby Berhad was founded in 1910 and is based in Petaling Jaya, Malaysia.

Full SMEBF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SMEBF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMEBF vs SCHDSMEBF vs JEPISMEBF vs OSMEBF vs KOSMEBF vs MAINSMEBF vs JNJSMEBF vs MRKSMEBF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.